519 related articles for article (PubMed ID: 9596274)
1. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.
Arber DA; Tamayo R; Weiss LM
Hum Pathol; 1998 May; 29(5):498-504. PubMed ID: 9596274
[TBL] [Abstract][Full Text] [Related]
2. Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow.
Natkunam Y; Rouse RV
Am J Surg Pathol; 2000 Jan; 24(1):81-91. PubMed ID: 10632491
[TBL] [Abstract][Full Text] [Related]
3. C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections.
Morini M; Bettini G; Preziosi R; Mandrioli L
J Histochem Cytochem; 2004 May; 52(5):705-8. PubMed ID: 15100248
[TBL] [Abstract][Full Text] [Related]
4. [The diagnostic and predictive role of kit (CD117)].
Dirnhofer S; Zimpfer A; Went P
Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
[TBL] [Abstract][Full Text] [Related]
5. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
Tsuura Y; Hiraki H; Watanabe K; Igarashi S; Shimamura K; Fukuda T; Suzuki T; Seito T
Virchows Arch; 1994; 424(2):135-41. PubMed ID: 7514077
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology.
Hosseini E; Pedram B; Bahrami AM; Touni SR; Malayeri HZ; Mokarizadeh A; Pourzaer M; Pourzaer M; Zehtabian S; Mohajer S; Ahmadi S
Tumour Biol; 2015 Feb; 36(2):929-37. PubMed ID: 25315185
[TBL] [Abstract][Full Text] [Related]
8. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia.
Fukuda T; Kamishima T; Tsuura Y; Suzuki T; Kakihara T; Naito M; Kishi K; Matsumoto K; Shibata A; Seito T
J Pathol; 1995 Oct; 177(2):139-46. PubMed ID: 7490680
[TBL] [Abstract][Full Text] [Related]
10. Adenoid basal carcinoma of the uterine cervix: clinicopathologic features of 12 cases with reference to CD117 expression.
Chen TD; Chuang HC; Lee LY
Int J Gynecol Pathol; 2012 Jan; 31(1):25-32. PubMed ID: 22123720
[TBL] [Abstract][Full Text] [Related]
11. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.
Miettinen M; Lasota J
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):205-20. PubMed ID: 16082245
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry.
Li CY
Leuk Res; 2001 Jul; 25(7):537-41. PubMed ID: 11377678
[TBL] [Abstract][Full Text] [Related]
13. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
Zigeuner R; Ratschek M; Langner C
BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-kit (CD117) in benign and malignant human endometrial epithelium.
Elmore LW; Domson K; Moore JR; Kornstein M; Burks RT
Arch Pathol Lab Med; 2001 Jan; 125(1):146-51. PubMed ID: 11151069
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell Tumors and Histiocytomas in Domestic Goats and Diagnostic Utility of CD117/c-Kit and Iba1 Immunohistochemistry.
O'Neill TW; Löhr CV
Vet Pathol; 2021 May; 58(3):508-515. PubMed ID: 33602038
[TBL] [Abstract][Full Text] [Related]
16. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.
Zmorzynski S; Kimicka-Szajwaj A; Szajwaj A; Czerwik-Marcinkowska J; Wojcierowski J
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275618
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
19. Mast cells or not? - CD117 positive cells in esophageal leiomyoma.
Ye JX; Liu Y; Qin Y; Ma XL; Zhong HH; Zhang Y; Shi XY
Histol Histopathol; 2015 May; 30(5):581-8. PubMed ID: 25487836
[TBL] [Abstract][Full Text] [Related]
20. CD117/KIT expression in pancreatic adenocarcinoma.
Bateman AC; Judd M; Radenkovic D; Johnson CD
Pancreas; 2008 Jan; 36(1):76-9. PubMed ID: 18192885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
